Results 21 to 30 of about 43,258 (202)

Strategies for active and passive pediatric RSV immunization

Therapeutic Advances in Vaccines and Immunotherapy, 2021
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in children worldwide, with the most severe disease occurring in very young infants. Despite half a century of research there still are no licensed RSV vaccines.
Katherine M. Eichinger, Jessica L. Kosanovich, Madeline Lipp, Kerry M. Empey, Nikolai Petrovsky   +4 more
doaj   +1 more source

PEMBERIAN IMUNISASI HEPATITIS B (PASIF) PADA BAYI YANG LAHIR DARI IBU HBsAg POSITIF

Indonesian Midwifery and Health Sciences Journal, 2021
Abstrak   Latar Belakang: Berdasarkan data Dinas Kesehatan Kota Surabaya tercatat 748 bayi lahir dari ibu dengan HBsAg positif diseluruh wilayah puskesmas kota Surabaya.
Ramadhani A. K. S, Juniastuti Juniastuti, Muhammad Ardian C. L   +2 more
doaj   +1 more source

Passive immunization reduces behavioral and neuropathological deficits in an alpha-synuclein transgenic model of Lewy body disease. [PDF]

PLoS ONE, 2011
Dementia with Lewy bodies (DLB) and Parkinson's Disease (PD) are common causes of motor and cognitive deficits and are associated with the abnormal accumulation of alpha-synuclein (α-syn). This study investigated whether passive immunization with a novel
Eliezer Masliah, Edward Rockenstein, Michael Mante, Leslie Crews, Brian Spencer, Anthony Adame, Christina Patrick, Margarita Trejo, Kiren Ubhi, Troy T Rohn, Sarah Mueller-Steiner, Peter Seubert, Robin Barbour, Lisa McConlogue, Manuel Buttini, Dora Games, Dale Schenk   +16 more
doaj   +1 more source

Passive Immunization

, 2021
Immediate protection of an animal can be achieved by passive immunization—the administration of preformed antibodies to a susceptible animal. These antibodies have historically been produced in hyperimmunized horses. The most widely employed are antitoxins directed against clostridia, such as tetanus or botulism, and snake venoms. Polyclonal antibodies
openaire   +2 more sources

Therapeutic versus neuroinflammatory effects of passive immunization is dependent on Aβ/amyloid burden in a transgenic mouse model of Alzheimer's disease

Journal of Neuroinflammation, 2010
Background Passive immunization with antibodies directed to Aβ decreases brain Aβ/amyloid burden and preserves memory in transgenic mouse models of Alzheimer's disease (AD). This therapeutic strategy is under intense scrutiny in clinical studies, but its
Bosetti Francesca, Wetzel Ronald, Dealwis Chris, Prendergast Jay S, Rebeck G William, Mocchetti Italo, Niikura Takako, Aid Saba, Shimoji Mika, Sidahmed Elkhansa, Minami S Sakura, Matsuoka Yasuji, Hoe Hyang-Sook, Turner R Scott   +13 more
doaj   +1 more source

Vertical transmission of maternal COVID-19 antibodies after CoronaVac vaccine: A case report

Revista da Sociedade Brasileira de Medicina Tropical, 2021
The use of coronavirus disease 2019 RNA vaccines in pregnant women led to reports on the first cases of newborns with antibodies to sudden acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a phenomenon that was unknown when using immunizations with ...
Bruno Thizon Menegali, Fabiana Schuelter-Trevisol, Alexandre Naime Barbosa, Talita Menegali Izidoro, Otto Henrique May Feurschuette, Chaiana Esmeraldino Mendes Marcon, Daisson José Trevisol   +6 more
doaj   +1 more source

Real-world use of monoclonal anti-tetanus toxin antibody for post-traumatic passive immunization: A nationwide survey in China

Chinese Journal of Traumatology
Purpose: To investigate the current status of monoclonal anti-tetanus toxin antibody used for passive immunization in the prevention and management of post-traumatic tetanus in China, and to provide evidence for the selection of passive immunization ...
Rui Huang, Xiaolu Deng, Hong Ren, Ke Lin, Chunhong Sun, Bogang Yan, Xuewei Yang, Xiaoxiong Chen   +7 more
doaj   +1 more source

A brief history of antibody-based therapy

Neurobiology of Disease, 2019
Active and passive immunization have been used to treat human disease for hundreds of years and improvements in technology and knowledge is only increasing the number of therapeutic applications.
M. Alpaugh, F. Cicchetti
doaj   +1 more source

Active and passive immunizations with HtsA, a streptococcal heme transporter protein, protect mice from subcutaneous group A Streptococcus infection

Journal of Microbiology, Immunology and Infection, 2020
Background/Purpose: HtsA (Streptococcus heme transporter A) is the lipoprotein component of the streptococcal heme ABC transporter (HtsABC). The aim of this study is to investigate whether the HtsA protein has immunoprotective effect against group A ...
Yingli Song, XiaoLan Zhang, Minghui Cai, Chunmei Lv, Yuan Zhao, Deqin Wei, Hui Zhu   +6 more
doaj   +1 more source

T cell mediated cerebral hemorrhages and microhemorrhages during passive Aβ immunization in APPPS1 transgenic mice

Molecular Neurodegeneration, 2011
Background Immunization against amyloid-β (Aβ), the peptide that accumulates in the form of senile plaques and in the cerebrovasculature in Alzheimer's disease (AD), causes a dramatic immune response that prevents plaque formation and clears accumulated ...
de Calignon Alix, Spires-Jones Tara L, Mielke Matthew, Mora J Rodrigo, Meyer-Luehmann Melanie, von Andrian Ulrich H, Hyman Bradley T   +6 more
doaj   +1 more source